ASPSH

References

content image
  1. IARC Working Group. IARC monographs on the evaluation of carcinogenic risks to humans: Human Papillomavirus. IARC Agency for Research on Cancer 1995:64
  2. Wallboomers JMM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
  3. Marrett LD et al. Cancer incidence in young adults in Canada: Preliminary results of a cancer surveillance project. In: Chronic Diseases in Canada 2002;23(2):58-64
  4. Statistics Canada. Able 102-0522. Deaths by cause, Chapter 11: Neoplasms ( C00 – D48), age group and sex, Canada, annual (2000-2002). CANSIM [Vital Statistics – Death Database].
  5. Statistics Canada Incidence of cancer of the vagina and vulva, Canada (C51.0-C51.9, C52.9). Health Statistics Division, Canadian Cancer Registry.
  6. Statistics Canada/CANSIM table 102-0522. Deaths, by cause, Chapter 11: Neoplasms (C00 to D48), age group and sex, Canada, 2000-2003.
  7. Brisson M et al. The health and economic burden of HPV infection, genital warts, cervical dysplasia and cervica cancer in Canada. Presentation, 7th Canadian Immunization Conference, December, 2006, Slide 25
  8. Public Health Agency of Canada, Canada Communicable Disease Report (CCDR*RMTC), An Advisory Committee Statement, National Advisory Committee on Immunization (NACI), Statement on Human Papillomavirus Vaccine, Pg. 23, Volume 33, ACS-2, February 15, 2007.